Alnylam Pharmaceuticals Aktie
261,00
EUR
-1,00
EUR
-0,38
%
300,39
USD
-6,21
USD
-2,03
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung